Tonabersat (SB-220453) 5mg 5mg | Purity Not Available
Adooq Bioscience
Tonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine attacks.
More Information Supplier PageTonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine attacks.
More Information Supplier PageTonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine attacks.
More Information Supplier PageTonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine attacks.
More Information Supplier PageTideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy
More Information Supplier PageTideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy
More Information Supplier PageTideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy
More Information Supplier PageTolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28?M.
More Information Supplier PageTolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28?M.
More Information Supplier Page